The role of myeloid-derived suppressor cells in chronic osteomyelitis
10.13431/j.cnki.immunol.j.20230116
- VernacularTitle:髓源性抑制细胞在慢性骨髓炎中的作用研究
- Author:
Jianbo FENG
1
;
Lidan YANG
;
Piaotao CHENG
;
Chencheng LI
;
Jinyue LIU
;
Jiachen PENG
Author Information
1. 563400遵义,正安县人民医院关节外科
- Keywords:
Myeloid-derived suppressor cells;
Osteomyelitis;
Staphylococcus aureus;
Bacterial biofilms
- From:
Immunological Journal
2023;39(10):893-899
- CountryChina
- Language:Chinese
-
Abstract:
Inhibitory cells derived from bone marrow are a kind of inhibitory cells derived from bone marrow.These cells are not only related to tumor growth,but also participate in the inflammatory immune process.Therefore,we established a rat model of chronic osteomyelitis,and used gemcitabine to inhibit the cell growth ratio of MDSCs.We detected the ratio of MDSCs in bone marrow and spleen of rats by flow cytometry and immunofluorescence,detected the changes of inflammatory factors in peripheral blood by ELISA,and analyzed the inflammatory factors(TNF-α,PCT,IL-4,IL-10,IL-11)in peripheral blood of normal rats,osteomyelitis rats and rats after gemcitabine inhibition.The results showed that the proportion of MDSCs cells in bone marrow and spleen of osteomyelitis model rats was increased,but it was significantly decreased in gemcitabine group(P<0.05).Levels of inflammatory factors(TNF-α,PCT,IL-4,IL-10,IL-17,IFN-γ,TGF-β)were positively correlated with the change of MDSCs cell proportion(P<0.05).From the results,it can be inferred that the change of the proportion of MDSCs cells in rat osteomyelitis is positively related to the inflammatory factors,and gemcitabine can reduce inflammatory factors by inhibiting MDSCs.